CANNTAB THERAPEUTICS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 CAD | -.--% |
|
-.--% | -.--% |
| Apr. 15 | Canntab Therapeutics Limited announced that it expects to receive CAD 0.1 million in funding | CI |
| 2023 | Canntab Therapeutics Limited Provide an Update on Product Delivery | CI |
Performance
| 1 year | -66.67% | ||
| 3 years | -99.51% | ||
| 5 years | -99.37% |
Volumes
marketsDaily volume
55 800
Estimated daily volume
55 800
Record volume 1
1 583 326
Record volume 2
1 571 550
Record volume 3
1 306 800
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (CAD)
142 012
Capitalization (USD)
142 012
Net sales ()
0
Free-Float
86.26 %
Free-Float capitalization (CAD)
122 496
Free-Float capitalization (USD)
122 496
Highs and lows
1 year
0.00
0.02
3 years
0.001.05
5 years
0.001.15
10 years
0.002.14
Indicators
Moving average 5 days
0.01
Moving average 20 days
0.01
Moving average 50 days
0.01
Moving average 100 days
0.01
Price spread / (MMA5)
-.--%
Price spread / (MMA20)
+40.00%
Price spread / (MMA50)
+86.00%
Price spread / (MMA100)
+126.00%
RSI 9 days
44.77
RSI 14 days
46.68
Sector Comparison - Alternative Medicine
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -.--% | -.--% | -.--% | -66.67% | 142K | ||
| +0.67% | +1.40% | -15.13% | -36.65% | 4.49B | ||
| +3.09% | +0.20% | -9.75% | +1.05% | 3.06B | ||
| +2.26% | +3.77% | +2.14% | -15.26% | 3.04B | ||
| -7.26% | -5.20% | -6.82% | -19.67% | 2.61B | ||
| +8.68% | +7.75% | +47.87% | +61.66% | 1.81B | ||
| -0.75% | -0.92% | +0.09% | -13.59% | 1.66B | ||
| +3.03% | +5.61% | -7.89% | -33.26% | 1.63B | ||
| -1.07% | 0.00% | -12.97% | -33.99% | 1.55B | ||
| -2.20% | -1.93% | +33.40% | +14.49% | 1.41B | ||
| -2.76% | +2.92% | +34.29% | -14.02% | 1.34B | ||
| -8.42% | -9.44% | -4.69% | -23.45% | 1.22B | ||
| +0.31% | -2.45% | -21.33% | -17.68% | 1.22B | ||
| -5.04% | -6.03% | -19.96% | -35.20% | 1.01B | ||
| +1.05% | +4.34% | -13.29% | -18.26% | 1B | ||
| +2.62% | +8.95% | +27.44% | +49.58% | 959M | ||
| Average | -0.36% | -0.40% | +2.09% | -12.56% | ||
| Weighted average by Cap. | -0.00% | -0.03% | -0.03% | -11.83% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -100.00% | ||
| 2023 | -66.67% | ||
| 2022 | -97.92% | ||
| 2021 | -10.00% | ||
| 2020 | +45.45% | ||
| 2019 | -51.75% | ||
| 2018 | +62.86% |
- Stock Market
- Equities
- PILL Stock
- Quotes Canntab Therapeutics Limited
